Myeloid sarcoma and acute myeloid leukaemia (AML) represent interconnected manifestations of myeloid malignancies. Myeloid sarcoma is an extramedullary tumour comprising immature myeloid cells, which ...

Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refers to granulocytes and monocytes generated from the bone marrow. Many cells under this term ...

The treatment showed effectiveness in achieving local control of acute myeloid leukemia (AML) that developed in the eyes of a pediatric patient. When AML is present outside of the bone marrow and ...

Meta-analysis of mutational site-specificity and concordance/discordance characteristics of myeloid sarcoma. This is an ASCO Meeting Abstract from the 2024 ASCO ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Granulocytic sarcomas are rare, destructive, extramedullary tumor masses that consist of immature granulocytic cells. The term "chloroma" is derived from the Greek word chloros (for green). It ...

Data presented at ASH suggested that CDK4/6 inhibitors given with chemo for Rb-deficient tumors could mitigate the risk of secondary myeloid neoplasms.

Triggering receptors expressed on myeloid cells (TREMs) are a cell surface receptor family found on granulocytes, monocytes, macrophages, and dendritic cells—as well as other myeloid cells in general.

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to ...

Broad tumor coverage Developed with our AI-Immunology™ platform, EVX-04 targets non-conventional ERV tumor antigens from the dark genome. These antigens are selectively expressed in specific tumors ...